XARELTO® is the #1 prescribed novel oral anticoagulant in the US*1

XARELTO® is available for multiple indications:

*Among Factor Xa inhibitors and direct thrombin inhibitors.

Reference:

  1. Data on file. Janssen Pharmaceuticals, Inc. Based on IMS Health, NPA Weekly, May 2014.